Why partner with us?
Pangaea is at the very forefront of molecular oncology research. Our multidisciplinary team is composed of both prestigious clinical and research professionals and combines expertise in preclinical cancer models with extensive experience in Biomarker Discovery, Diagnostics, Drug Development and patient care.
Is to turn breakthrough innovations into diagnostic products and services that will improve response to targeted cancer treatments, as well as help bring new, more effective therapies to market. To achieve our goals, we follow an open innovation model and source our pipeline from external collaborators, outsource proprietary product development, and actively collaborate with leading industry and academic partners at national and international level.
We are always looking for strategic alliances for distribution and to complement our in-house R&D pipeline and diversify our portfolio. If you have a business opportunity you’d like to discuss, please contact us.